SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about outcome of resolution

27 Mar 2023 Evaluate
Hester Biosciences has informed that the Board of Directors by circulation of resolution, have approved the resolutions listed into the outcome as attached. The second term of Naman Patel and Amit Shukla, as independent directors, will be completed by the end of the day of 31 March 2023. Therefore, from 1 April 2023, both directors will cease to be directors of the Company. The shareholders' approval will be taken for said resolutions through postal ballot and postal ballot notice to be submitted to the exchange separately. The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are mentioned in Annexure attached.

The above information is a part of company’s filings submitted to BSE 

Hester Biosciences Share Price

1482.05 4.80 (0.32%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×